BRIEF-Endo to pay $173 million over Lidoderm marketing

NEW YORK Fri Feb 21, 2014 12:33pm EST

NEW YORK Feb 21 (Reuters) - Endo Health Solutions Inc agreed to pay $173 million to U.S. state and federal authorities to resolve allegations of unlawful marketing of the drug Lidoderm, New York Attorney General Eric Schneiderman said in a statement.

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.